Intravenous Injection of Saeng Maek San - A Safe Method of Treatment in Rats
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Objectives: This study evaluated the single-dose toxicity of Saeng Maek San (SMS) in rats. Methods: All experiments were conducted at Biotoxtech (Chungwon, Korea), an institute authorized to perform non-clinical studies under the regulations of Good Laboratory Practice (GLP). A single-dose intravenous toxicity study was carried out on 40 6-week-old Sprague-Daley rats. The animals were randomly divided into the following four groups of ten animals each: Group 1 (G1) was the control group, with each animal receiving an intravenous injection of 1.0 mL of saline, and Groups 2, 3 and 4 (G2, G3 and G4) were the experimental groups, with the animals in the groups receiving an injection of 0.1, 0.5 and 1.0 mL of SMS, respectively. Mortality, clinical signs, body-weight changes and gross pathological findings were observed for 14 days following a single administration of SMS or saline. Organ weights, clinical chemistry and hematology were analyzed at 14 days. This study was conducted with the approval of the Institutional Animal Ethics Committee. Results: No deaths occurred in any of the four groups, indicating that the lethal dose of SMS in rats is greater than 1.0 mL/animal. Some changes in weights of male rats between the control group and the experimental groups were observed, but no significant changes in the weights of female rats were noted. To identify abnormalities in organs and tissues, we stained representative sections of each specified organ with hematoxylin and eosin for examination with a light microscope. No significant abnormalities were observed in any of the organs or tissues. Conclusion: The results suggest that intravenous injection of Saeng Maek San is a safe method of treatment.
Abstract
Objectives: This study evaluated the single-dose toxicity of Saeng Maek San (SMS) in rats. Methods: All experiments were conducted at Biotoxtech (Chungwon, Korea), an institute authorized to perform non-clinical studies under the regulations of Good Laboratory Practice (GLP). A single-dose intravenous toxicity study was carried out on 40 6-week-old Sprague-Daley rats. The animals were randomly divided into the following four groups of ten animals each: Group 1 (G1) was the control group, with each animal receiving an intravenous injection of 1.0 mL of saline, and Groups 2, 3 and 4 (G2, G3 and G4) were the experimental groups, with the animals in the groups receiving an injection of 0.1, 0.5 and 1.0 mL of SMS, respectively. Mortality, clinical signs, body-weight changes and gross pathological findings were observed for 14 days following a single administration of SMS or saline. Organ weights, clinical chemistry and hematology were analyzed at 14 days. This study was conducted with the approval of the Institutional Animal Ethics Committee. Results: No deaths occurred in any of the four groups, indicating that the lethal dose of SMS in rats is greater than 1.0 mL/animal. Some changes in weights of male rats between the control group and the experimental groups were observed, but no significant changes in the weights of female rats were noted. To identify abnormalities in organs and tissues, we stained representative sections of each specified organ with hematoxylin and eosin for examination with a light microscope. No significant abnormalities were observed in any of the organs or tissues. Conclusion: The results suggest that intravenous injection of Saeng Maek San is a safe method of treatment.
참고문헌 (31)
- Ichikawa H., "In vitro antioxidant potentials of traditional Chinese medicine, Shengmai San and their relation to in vivo protective effect on cerebral oxidative damage in rats", Biol Pharm Bull, 25(7), pp.898~903 (2002)
- Li LH., "Protective effects of Shengmai San and its three fractions on cerebral ischemia–reperfusion injury", Chin J Nat Med, 11(3), pp.222~230 (2013)
- Zhou Q., "Shengmai (a traditional Chinese herbal medicine) for heart failure", Cochrane Database Syst Rev, 14(4) (2014)
- Wang NL., "Shengmai San, a Chinese herbal medicine protects against rat heat stroke by reducing inflammatory cytokines and nitric oxide formation", J Pharmacol Sci, 98(1), pp.1~7 (2005)
- 서영배, "Shengmai-san-Mediated Enhancement of Regenerative Responses of Spinal Cord Axons After Injury in Rats", JOURNAL OF PHARMACOLOGICAL SCIENCES, 110(4), pp.483~492 (2009), JAPANESE PHARMACOLOGICAL SOC
- Gurney ME., "Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation", Science, 264(5166), pp.1772~1775 (1994)
- Wu Y., "Effect of Shengmaisan on learning and memory abilities and hippocampal nitric oxide synthase expression and neuronal apoptosis in rats with vascular dementia", Nan Fang Yi Ke Da Xue Xue Bao, 30(6), pp.1327~1329 (2010)
- Xuejiang W., "Prevention and repair of cerebral ischemia-reperfusion injury by Chinese herbal medicine, shengmai san, in rats", Free Radic Res, 31(5), pp.449~455 (1999)
- Nishida H., "Amyloid-beta-induced cytotoxicity of PC-12 cell was attenuated by Shengmai-san through redox regulation and outgrowth induction", J Pharmacol Sci, 104(1), pp.73~81 (2007)
- Cheng HY., "Schizandrin protects primary cultures of rat cortical cells from glutamate-induced excitotoxicity", J Pharmacol Sci, 107(1), pp.21~31 (2008)
- Huang YL., "Possible mechanism of the anti-inflammatory activity of ruscogenin : role of intercellular adhesion molecule-1 and nuclear factor-kappaB", J Pharmacol Sci, 108(2), pp.198~205 (2008)
- Chen Z., "Neuroprotective effect of ginsenoside Rb1 on glutamate-induced neurotoxicity : with emphasis on autophagy", Neurosci Lett, 482(3), pp.264~268 (2010)
- Liu Q., "Ginsenoside Rg1 protects against hydrogen peroxide-induced cell death in PC12 cells via inhibiting NF-κB activation", Neurochem Int, 58(1), pp.119~125 (2011)
- Chiu PY., "Co-treatment with Shengmai San-derived herbal product ameliorates chronic ethanol-induced liver damage in rats", Rejuvenation Res, 14(1), pp.17~23 (2011)
- Ma ST., "Safety evaluation of steroidal saponin DT-13 isolated from the tuber of Liriope muscari(Decne. )Baily", Food Chem Toxicol, 49(9), pp.2243~2251 (2011)
- Tian YQ., "Anti-inflammatory effects of aqueous extract from Radix Liriope muscari and its major active fraction and component", Chin J Nat Med, 9(3), pp.222~226 (2011)
- Guo Z., "A combination of four active compounds alleviates cerebral ischemia-reperfusion injury in correlation with inhibition of autophagy and modulation of AMPK", mTOR and JNK pathways, 2014, pp.7, ~
- Konishi T., "Brain oxidative stress as basic target of antioxidant traditional oriental medicines", Neurochem Res, 34(4), pp.711~716 (2009)
- Xu N., "HPLC", MS, J Pharm Biomed Anal, pp.2011, 55(1)[DOI]
- Mok TS., "A double-blind placebo-controlled randomized study of Chinese herbal medicine as complementary therapy for reduction of chemotherapy-induced toxicity", Ann Oncol, 18(4), pp.768~774 (2007)
- Lee IY., "Sheng mai san, a Chinese herbal medicine, protects against renal ischemic injury during heat stroke in the rat", Clin Exp Pharmacol Physiol, 32(9), pp.742~748 (2005)
- Zhang F., "Sheng Mai Zhusheye improves the viability and movement parameters of human sperm in vitro", Zhonghua Nan Ke Xue, 15(5), pp.468~471 (2009)
- Barton DL., "Pilot study of Panax quinquefolius(American ginseng)to improve cancer-related fatigue : a randomized., double-blind., dose-finding evaluation : NCCTG trial N03CA", Support Care Cancer, 18(2), pp.179~187 (2010)
- Blanco M., "Platelets, inflammation, and atherothrombotic neurovascular disease: the role of endothelial dysfunction", Cerebrovasc Dis, (Suppl 2), pp.S32~S39 (2005)
- Fang F., "Multi-faced neuroprotective effects of Ginsenoside Rg1 in an Alzheimer mouse model", Biochim (2012)
- Wang J., "Anti-fatigue activity of the water-soluble polysaccharides isolated from Panax ginseng C. A. Meyer", J Ethnopharmacol, 130(2), pp.421~423 (2010)
- Chen X., "Anti-diabetic effects of water extract and crude polysaccharides from tuberous root of Liriope spicata var. prolifera in mice", J Ethnopharmacol, 122(2), pp.205~209 (2009)
- Liu GT., "Pharmacological actions and clinical use of fructus schizandrae", Chin Med J(Engl), 102(10), pp.740~749 (1989)
- S., "Parasuraman. Toxicological screening", J Pharmacol Pharmacother, 2(2), pp.74~79 (2011)
- Kim YG., "Toxicology", pp.15~18, Donghwagisul
- Toxicity Test Guidelines for Safety Evaluation of Drugs, "Korea Food and Drug Administration (KFDA)", ~, pp.Notification No. 2005-60 (2005)